Literature DB >> 21487885

Challenges with identification of angiogenesis biomarkers in cancer.

Eugenia Halkia, Nikolaos Kalinoglou.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21487885     DOI: 10.1007/s00464-011-1623-3

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


× No keyword cloud information.
  28 in total

1.  Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations.

Authors:  Dimitrios H Roukos; Niki J Agnanti; Evangelos Paraskevaidis; Angelos M Kappas
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

2.  Complete genome sequencing and network modeling to overcome trastuzumab resistance.

Authors:  Dimitrios H Roukos
Journal:  Pharmacogenomics       Date:  2010-08       Impact factor: 2.533

3.  Laparoscopic surgery for gastric cancer: comparative-effectiveness research and future trends.

Authors:  Christos G Katsios; George Baltogiannis; Dimitrios H Roukos
Journal:  Expert Rev Anticancer Ther       Date:  2010-04       Impact factor: 4.512

Review 4.  Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks.

Authors:  D H Roukos
Journal:  Pharmacogenomics J       Date:  2010-10-26       Impact factor: 3.550

5.  Cancer: The nuances of therapy.

Authors:  Lee M Ellis; David A Reardon
Journal:  Nature       Date:  2009-03-19       Impact factor: 49.962

6.  Current concerns and challenges regarding tailored anti-angiogenic therapy in cancer.

Authors:  Dimitrios H Roukos; Andreas Tzakos; George Zografos
Journal:  Expert Rev Anticancer Ther       Date:  2009-10       Impact factor: 4.512

7.  'Big' science: genome regulatory networks and novel molecular tools to improve health.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Mol Diagn       Date:  2011-03       Impact factor: 5.225

8.  Measurable evidence of miRNAs as regulators of cancer networks and therapeutic targets.

Authors:  Dimitrios H Roukos
Journal:  Expert Rev Med Devices       Date:  2011-03       Impact factor: 3.166

9.  From tumor size and HER2 status to systems oncology for very early breast cancer treatment.

Authors:  Dimitrios H Roukos; Dimosthenis Ziogas
Journal:  Expert Rev Anticancer Ther       Date:  2010-02       Impact factor: 4.512

10.  Cancer genome explosion and systems biology: impact on surgical oncology?

Authors:  Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2011-01       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.